High dose
Sponsors
The First Affiliated Hospital of Anhui Medical University, Shulan (Hangzhou) Hospital, University of Missouri-Columbia, University of Calgary, University of Toronto
Conditions
Acute Myocardial InfarctionBioavailabilityChronic Spinal Cord InjuryChronic hepatitis BColitis, UlcerativeFood AllergyGraves' DiseaseHIV Infections
Early Phase 1
A Single-Center, Open-label, Single-Arm, Dose Escalation and Dose Extension Investigator-Initiated Study (IIT) to Evaluate the Safety, Efficacy and Pharmacokinetic of EPI-001 Injection for the Treatment of Heterozygous Familial Hypercholesterolemia (HeFH)
Active, not recruitingChiCTR2400081208
Start: 2024-02-27Updated: 2024-03-04
A study on the safety, tolerance, pharmacokinetics and pharmacodynamics of EPI-003T injection in the treatment of chronic hepatitis B subjects who have been treated with nucleoside (acid) analogues
Active, not recruitingChiCTR2500110861
Start: 2025-10-22Updated: 2025-10-27
Phase 1
A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults
CompletedNCT00549523
Start: 2008-04-30End: 2012-01-31Updated: 2016-10-10
Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults
CompletedNCT04439695
Start: 2020-06-25End: 2021-07-28Updated: 2021-09-16
Phase 2
Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
SuspendedNCT01601093
Start: 2011-11-30End: 2022-12-15Target: 288Updated: 2019-07-05
A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M
CompletedNCT02493712
Start: 2016-01-31End: 2019-04-30Updated: 2021-10-26
Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction
CompletedNCT05485818
Start: 2020-11-23End: 2021-11-18Updated: 2022-08-03
A study to expand safety and immunogenicity data with the second generation of the Shigella bioconjugate tetravalent (Shigella4V2) in 9-month-old Kenyan infants.
Active, not recruitingPACTR202408653853505
Start: 2025-02-17Target: 110Updated: 2026-01-27
Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
CompletedNCT07035054
Start: 2024-04-20End: 2024-11-30Updated: 2025-06-24
Unknown Phase
Fathers and Late Preterm Babies Study
CompletedNCT01056653
Start: 2008-12-31End: 2013-01-31Updated: 2017-03-29
Vitamin D Fortified Cheese and Well-being in the Institutionalized Elderly
NCT01555424
Start: 2012-02-29End: 2012-04-30Updated: 2012-03-15
Comparative Study of Different I-131 Doses in Graves' Disease
NCT02114619
Start: 2013-05-31End: 2016-12-31Target: 450Updated: 2014-04-15
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
CompletedNCT04074616
Start: 2019-11-19End: 2023-04-20Updated: 2024-10-15
High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety
RecruitingNCT05158413
Start: 2022-03-31End: 2025-06-30Target: 40Updated: 2024-03-20
Food Supplement Effect on Overweight or Moderate Obesity
CompletedNCT05178667
Start: 2022-01-06End: 2022-10-31Updated: 2022-12-16
Factorial Trial Testing Guided Thinking Tasks to Optimize a Physical Activity Intervention
NCT05235360
Start: 2022-02-14End: 2023-07-31Target: 192Updated: 2022-02-28
Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)
CompletedNCT06214338
Start: 2024-02-12End: 2024-04-15Updated: 2024-05-20
ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension
RecruitingNCT06264622
Start: 2024-02-26End: 2024-12-31Target: 180Updated: 2024-02-20